Key Considerations in Biosimilars Development

被引：0
|
作者：
Donninger, Raymond
Bower, Joe
Kaiser, Raymond
Estdale, Sian
Carlsen, John
机构：
来源：
BIOPHARM INTERNATIONAL | 2012年 / 25卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：37 / 39
页数：3
相关论文
共 50 条
  • [21] Development of biosimilars
    Schellekens, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S70 - S70
  • [22] Biosimilars: Current Scientific and Regulatory Considerations
    Chugh, Preeta Kaur
    Roy, Vandana
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (01): : 53 - 63
  • [23] BIOSIMILARS: CONSIDERATIONS FOR ONCOLOGY NURSING PROFESSIONALS
    Mayden, Kelley
    Larson, Paul
    Geiger, Danielle
    Watson, Holly
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E139 - E139
  • [24] Key Considerations for Development and Production of Vaccine Products
    Rathore, Anurag S.
    Jadhav, Suresh
    Bhalghat, Mahesh
    Kandawalla, Shiraz
    Ray, Suma
    Patra, Ashok Kumar
    BIOPHARM INTERNATIONAL, 2012, : S28 - S34
  • [25] The antibiogram: key considerations for its development and utilization
    Truong, William R.
    Hidayat, Levita
    Bolaris, Michael A.
    Nguyen, Lee
    Yamaki, Jason
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (02):
  • [26] Key considerations in the development of defect sampling methodologies
    McIntyre, M
    Nurani, RK
    Akella, R
    1996 ADVANCED SEMICONDUCTOR MANUFACTURING CONFERENCE AND WORKSHOP - ASMC 96 PROCEEDINGS: THEME - INNOVATIVE APPROACHES TO GROWTH IN THE SEMICONDUCTOR INDUSTRY, 1996, : 81 - 85
  • [27] Considerations related to comparative clinical studies for biosimilars
    Rathore, Anurag S.
    Stevenson, James G.
    Chhabra, Hemlata
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (03) : 265 - 273
  • [28] Regulatory considerations in biosimilars: Asia pacific regions
    Rathore, Anurag S.
    Bhargava, Ankita
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2021, 51 (01): : 1 - 8
  • [29] Regulatory considerations in biosimilars: Latin America region
    Rathore, Anurag S.
    Bhargava, Ankita
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2021, 51 (02): : 201 - 206
  • [30] Pharmacoeconomics of Cancer Therapies: Considerations With the Introduction of Biosimilars
    Henry, David
    Taylor, Carrie
    SEMINARS IN ONCOLOGY, 2014, 41 (02) : S13 - S20
12345